Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Up 178% Overnight, Should Investors Buy Valens (TSX:VLNS) Stock?

Published 2021-11-18, 10:14 a/m
Updated 2021-11-18, 10:15 a/m
© Reuters.  Up 178% Overnight, Should Investors Buy Valens (TSX:VLNS) Stock?

© Reuters. Up 178% Overnight, Should Investors Buy Valens (TSX:VLNS) Stock?

Valens (TSX:VLNS) shares soared 178% in early-morning trading on Nov. 18 from news its chief executive officer Tyler Robson is a recipient of Canada’s “Top 40 Under 40” award. Shares of Valens stock went from $1.78 to $5.28 overnight from the news announced Thursday morning.

What happened? The award isn’t the only reason investors were jumping on Valens stock. In the press release, investors learn exactly what helped him receive the honour. Beyond his “team player” attitude, Robson led four major acquisitions. This included that of LYF Technologies, Verse Cannabis, Citizen Stash, and Green Roads in Florida.

This last acquisition marks Valens stock entry into the United States. And with more rumours coming out that federal legalization could happen sooner as opposed to later, Valens stock could be a strong entry point — especially as other cannabis stocks crash around it.

So what? With only one acquisition in the last year aimed at the U.S., should investors really get excited about federal legalization and Valens stock? In short: yes. The cannabis stock also announced its on the way to having a Nasdaq listing. This could boost the share price even higher with access to the U.S. and could mean further U.S. acquisitions in the future.

Furthermore, we can’t ignore that other cannabis company CEOs simply did not make the cut on the “40 Under 40” list. In a time when cannabis companies are struggling to make ends meet, Valens stock seems to be the odd one out.

Of course, the nominees are chosen on more than the numbers, including sustainability and market leadership. However, investors can’t ignore Valens stock’s finances. The company saw gross revenue rise 32.7% year over year during its third quarter, with provincial sales up 20% compared to the second quarter.

It also closed its Citizen Stash acquisition. And according to Valens, the “strategic acquisition of Citizen Stash expected to propel Valens’s asset-light entry into the flower and pre-roll segments, the two largest categories in the Canadian cannabis market currently accounting for over 70% of retail sales.”

Now what? Valens stock ended the quarter with about $31 million on the books. This while other cannabis stocks try and make a profit. The acquisitions of late may be just the tip of the iceberg, as the company continues to bring in more cash.

Analysts have been touting Valens stock as undervalued for a while, marking it worth around $4 per share, while it traded around $1. During the latest earnings report, analysts bumped it even higher thanks to acquisitions and entry into the U.S.

Sales should continue to accelerate thanks to the acquisitions into full year 2022, according to analysts. Further, there is an entry into Quebec, a manufacturing agreement, and full-quarter acquisition sales to look forward to.

So, yes, even with Valens stock climbing higher, according to analysts, it’s still a buy. The company has remained responsible and focused on shareholder interests in growing sales at a steady pace.

Shares currently trade at $5 as of writing, up 137% year to date. Furthermore, analysts give it a potential upside of 131% for the next year!

The post Up 178% Overnight, Should Investors Buy Valens (TSX:VLNS) Stock? appeared first on The Motley Fool Canada.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends The Valens Company Inc.

This Article Was First Published on The Motley Fool

Latest comments

At least have the balla to issue a correction and apology. Fire this contributor!
What an idiot! Fire this guy now.
It was a reverse split!! Dd anyone?? Lol
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.